Press releases 2016

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
2016-11-21 17:00
News
IR
Swedish
Corporate Information
Other Corporate Information
XVIVO Perfusion har godkänts för notering på Nasdaq Stockholm och offentliggör prospekt
2016-11-21 17:00
News
IR
English
Corporate Information
Other Corporate Information
XVIVO Perfusion has been approved for listing on Nasdaq Stockholm and publishes prospectus
2016-10-27 17:15
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
Clarification of news about two LS™ contract signed in Spain
2016-10-27 17:15
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Förtydligande angående två LS™ kontrakt i Spanien
2016-10-27 08:30
News
IR
English
Regulatory
MAR
Report
Interim
Q3
XVIVO Perfusion Interim report January – September 2016
2016-10-27 08:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q3
Delårsrapport januari – september 2016
2016-10-27 07:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Två LS™ kontrakt i Spanien
2016-10-27 07:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
Two LS™ contract signed in Spain
2016-10-21 10:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2016-10-21 10:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Interim Report
2016-09-20 14:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Nomination Committee
Valberedning i XVIVO Perfusion AB (publ)
2016-09-20 14:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Nomination Committee
Election Committee of XVIVO Perfusion AB (publ)
2016-07-15 08:30
News
IR
English
Regulatory
VPML
Report
Interim
Q2
XVIVO Perfusion Interim report January – June 2016
2016-07-15 08:30
News
IR
Swedish
Regulatory
VPML
Report
Interim
Q2
Delårsrapport januari - juni 2016
2016-07-15 07:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Förlängd acceptperiod i XVIVO Perfusions bud på Vivoline Medical avslutad
2016-07-15 07:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
Extension of the acceptance period of XVIVO Perfusion’s public offer on Vivoline Medical has ended
2016-07-08 09:00
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Interim Report
2016-07-08 09:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2016-07-08 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Teckningsoptionsprogrammet fulltecknat
2016-07-08 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Share warrant program fully subscribed
2016-06-22 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Lungcancerpatient ges kemoterapi genom In Vivo Lung perfusion med STEEN Solution™
2016-06-22 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Lung Cancer Patient given Chemotherapy through In Vivo Lung Perfusion with STEEN Solution™
2016-06-21 07:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion förlänger acceptperioden avseende budet på Vivoline Medical
2016-06-21 07:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion extends the acceptance period for the public offer on Vivoline Medical
2016-06-17 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XPS™ contract signed with leading hospital in Alabama
2016-06-17 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XPS™ kontrakt med klinik i Alabama
2016-06-15 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Första patienten i PrimECC studien inkluderad
2016-06-15 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
First patient in PrimECC study included
2016-06-08 07:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion declares the public offer on Vivoline Medical unconditional, announces the outcome and extends the acceptance period
2016-06-08 07:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion förklarar budet på Vivoline Medical ovillkorat, offentliggör utfallet och förlänger acceptperioden
2016-05-17 08:30
News
IR
English
Corporate Information
Other Corporate Information
Conference call regarding information on the offer made to Vivoline’s shareholders
2016-05-17 08:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende Information angående Erbjudandet till Vivolines aktieägare
2016-05-10 14:00
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion published prospectus regarding the public offer to the holders of shares and warrants of series 2015/2016 in Vivoline Medical
2016-05-10 14:00
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion offentliggör prospekt avseende erbjudandet till ägare av aktier och teckningsoptioner av serie 2015/2016 i Vivoline Medical
2016-05-04 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
Report from Annual General Meeting of XVIVO Perfusion AB (publ)
2016-05-04 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Report of the AGM
Kommuniké från årsstämma i XVIVO Perfusion AB (publ)
2016-04-26 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Report
Interim
Q1
XVIVO Perfusion delårsrapport januari - mars 2016
2016-04-26 08:30
News
IR
English
Regulatory
Listing Regulation
Report
Interim
Q1
XVIVO Perfusion Interim report January – March 2016
2016-04-22 08:30
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Interim Report
2016-04-22 08:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende delårsrapport
2016-04-18 07:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion announces a recommended public offer to the holders of shares and warrants of series 2015/2016 in Vivoline Medical
2016-04-18 07:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion lämnar ett rekommenderat offentligt erbjudande till ägare av aktier och teckningsoptioner av serie 2015/2016 i Vivoline Medical
2016-04-15 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XPS™ contract signed with leading hospital in Boston
2016-04-15 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XPS™ kontrakt med klinik i Boston
2016-04-11 08:30
News
IR
Swedish
Regulatory
VPML
Report
Annual
Årsredovisning 2015
2016-04-11 08:30
News
IR
English
Regulatory
VPML
Corporate Information
Other Corporate Information
Annual Report 2015
2016-03-31 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Kallelse till årsstämma i XVIVO Perfusion AB (publ)
2016-03-31 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
General meeting
Notice
Annual General Meeting of XVIVO Perfusion AB (publ)
2016-02-24 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XPS™ to be delivered to the first clinic in France
2016-02-24 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XPS™ levereras till första kliniken i Frankrike
2016-02-16 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
PERFADEX® and STEEN Solution™ approved in Russia
2016-02-16 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
PERFADEX® och STEEN Solution™ godkända i Ryssland
2016-02-05 16:00
News
IR
Swedish
Corporate Information
Other Corporate Information
XVIVO Perfusion AB upptas till handel på Nasdaq First North Premier
2016-02-05 16:00
News
IR
English
Corporate Information
Other Corporate Information
XVIVO Perfusion AB admitted to trading on Nasdaq First North Premier
2016-02-04 08:30
News
IR
English
Regulatory
VPML
Report
Interim
Yearend
Report on operations 2015
2016-02-04 08:30
News
IR
Swedish
Regulatory
VPML
Report
Interim
Yearend
Bokslutskommuniké 2015
2016-01-29 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XPS™ till Schweiz
2016-01-29 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XPS™ to Switzerland
2016-01-28 08:30
News
IR
English
Corporate Information
Other Corporate Information
Conference call on Report on Operations 2015
2016-01-28 08:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Telefonkonferens avseende bokslutskommuniké 2015
2016-01-07 08:30
News
IR
English
Corporate Information
Other Corporate Information
PrimECC has been granted CE mark
2016-01-07 08:30
News
IR
Swedish
Corporate Information
Other Corporate Information
PrimECC har erhållit CE-märke
2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
2016-10-27 17:15
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
Clarification of news about two LS™ contract signed in Spain
2016-10-27 17:15
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Förtydligande angående två LS™ kontrakt i Spanien
2016-10-27 08:30
News
IR
English
Regulatory
MAR
Report
Interim
Q3
XVIVO Perfusion Interim report January – September 2016
2016-10-27 08:30
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q3
Delårsrapport januari – september 2016
2016-10-27 07:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Två LS™ kontrakt i Spanien
2016-10-27 07:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
Two LS™ contract signed in Spain
2016-09-20 14:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Nomination Committee
Valberedning i XVIVO Perfusion AB (publ)
2016-09-20 14:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Nomination Committee
Election Committee of XVIVO Perfusion AB (publ)
2016-07-15 08:30
News
IR
English
Regulatory
VPML
Report
Interim
Q2
XVIVO Perfusion Interim report January – June 2016
2016-07-15 08:30
News
IR
Swedish
Regulatory
VPML
Report
Interim
Q2
Delårsrapport januari - juni 2016
2016-07-15 07:30
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Förlängd acceptperiod i XVIVO Perfusions bud på Vivoline Medical avslutad
2016-07-15 07:30
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
Extension of the acceptance period of XVIVO Perfusion’s public offer on Vivoline Medical has ended
2016-07-08 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Teckningsoptionsprogrammet fulltecknat
2016-07-08 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Share warrant program fully subscribed
2016-06-22 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Lungcancerpatient ges kemoterapi genom In Vivo Lung perfusion med STEEN Solution™
2016-06-22 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
Lung Cancer Patient given Chemotherapy through In Vivo Lung Perfusion with STEEN Solution™
2016-06-21 07:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion förlänger acceptperioden avseende budet på Vivoline Medical
2016-06-21 07:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XVIVO Perfusion extends the acceptance period for the public offer on Vivoline Medical
2016-06-17 08:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XPS™ contract signed with leading hospital in Alabama
2016-06-17 08:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Other Corporate Information
XPS™ kontrakt med klinik i Alabama
Next